RNAi Therapeutics. RNAi Therapy . RNAi-Based Therapeutics . RNAi-Based Therapy . RNAi Based Therapy . RNAi Therapies . RNAi-Based Therapies . Therapies, RNAi . Therapies, RNAi-Based . Therapy, RNAi . Therapy, RNAi-Based . A form of disease treatment which involves the silencing of genes that are associated with a disease by the process of RNA INTERFERENCE. . 1.00
Genome Components. Component, Genome . Components, Genome . Genome Component . The parts of a GENOME sequence that are involved with the different functions or properties of genomes as a whole as opposed to those of individual GENES. . 0.41
Rare Diseases. Orphan Diseases . Disease, Orphan . Disease, Rare . Diseases, Orphan . Diseases, Rare . Orphan Disease . Rare Disease . A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment. . 0.40
Protective Agents. Protective Drugs . Agents, Protective . Drugs, Protective . Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. . 0.39
Disease Progression. Disease Exacerbation . Disease Progressions . Progression, Disease . Progressions, Disease . The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. . 0.38